Hepatocyte Growth Factor Enhances Engraftment and Function of Nonhuman Primate Islets

OBJECTIVE—Adenoviral delivery of hepatocyte growth factor (HGF) to rodent islets improves islet graft survival and function, markedly reducing the number of islets required to achieve glucose control. Here, we asked whether these prior observations in rodent models extend to nonhuman primate (NHP) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiaschi-Taesch, Nathalie M., Berman, Dora M., Sicari, Brian M., Takane, Karen K., Garcia-Ocaña, Adolfo, Ricordi, Camillo, Kenyon, Norma S., Stewart, Andrew F.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2008
Materias:
Islet Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2551685/
https://www.ncbi.nlm.nih.gov/pubmed/18820214
http://dx.doi.org/10.2337/db08-1085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2551685/
https://www.ncbi.nlm.nih.gov/pubmed/18820214
http://dx.doi.org/10.2337/db08-1085

Ejemplares similares